Results 41 to 50 of about 1,615,665 (249)

Pulmonary arterial hypertension patients display normal kinetics of clot formation using thrombelastography

open access: yesPulmonary Circulation, 2021
Pulmonary arterial hypertension is characterized by endothelial dysfunction and microthrombi formation. The role of anticoagulation remains controversial, with studies demonstrating inconsistent effects on pulmonary arterial hypertension mortality ...
Mengyun Lu   +14 more
doaj   +1 more source

Biomarkers in Pulmonary Arterial Hypertension

open access: yesDiagnostics, 2022
Pulmonary arterial hypertension (PAH) is a severe medical condition characterized by elevated pulmonary vascular resistance (PVR), right ventricular (RV) failure, and death in the absence of appropriate treatment. The progression and prognosis are strictly related to the etiology, biochemical parameters, and treatment response.
Silvana Elena Hojda   +2 more
openaire   +3 more sources

Schistosomiasis Pulmonary Arterial Hypertension [PDF]

open access: yesFrontiers in Immunology, 2020
Pulmonary arterial hypertension (PAH) is a disease of the lung blood vessels that results in right heart failure. PAH is thought to occur in about 5% to 10% of patients with hepatosplenic schistosomiasis, particularly due to S. mansoni. The lung blood vessel injury may result from a combination of embolization of eggs through portocaval shunts into the
Jean Pierre Sibomana   +24 more
openaire   +5 more sources

Anticoagulation Treatment Response Among Phenotypic ESUS Clusters: Evidence From CASPR

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate treatment effect heterogeneity across phenotypic clusters of patients with cryptogenic embolic stroke using causal inference methods. Methods From a retrospective, multicenter cohort of patients with cryptogenic embolic stroke, we estimated the treatment effect of anticoagulation versus antiplatelet therapy in patients ...
Elena Badillo Goicoechea   +53 more
wiley   +1 more source

Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension

open access: yes, 2011
Background: Tadalafil 40 mg orally once daily, was shown to be well-tolerated and efficacious for pulmonary arterial hypertension in a 16-week, double-blind, placebo (PBO)-controlled trial.
Simonneau G   +20 more
core   +2 more sources

Adult congenital heart care in the COVID-19 era, and beyond: A call for actionKey Points

open access: yesInternational Journal of Cardiology Congenital Heart Disease, 2020
While virus epidemics are nothing new to man, the scale, speed of global spread and immediacy of the COVID-19 pandemic have been truly unprecedented [1].
Michael A. Gatzoulis   +8 more
doaj   +1 more source

Pulmonary hypertension and pulmonary artery dissection [PDF]

open access: yesJornal Brasileiro de Pneumologia, 2013
Pulmonary artery dissection is a fatal complication of long-standing pulmonary hypertension, manifesting as acute, stabbing chest pain, progressive dyspnea, cardiogenic shock, or sudden death. Its incidence has been underestimated, and therapeutic options are still scarce.
Ricardo de Amorim Corrêa   +5 more
openaire   +3 more sources

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

open access: yesArthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos   +2 more
wiley   +1 more source

Impact of the updated hemodynamic definitions on diagnosis rates of pulmonary hypertension

open access: yesPulmonary Circulation, 2020
We evaluated whether updated pulmonary hypertension definitive criteria proposed in sixth World Symposium on Pulmonary Hypertension had an impact on diagnosis of overall pulmonary hypertension and pre-capillary and combined pre- and post-capillary ...
Seda Tanyeri   +15 more
doaj   +1 more source

Oxidative stress in patients with pulmonary hypertension

open access: yesAdvances in Redox Research, 2022
Rationale: Pulmonary arterial hypertension is a devastating cardiovascular disease that is progressive and fatal despite advances in therapy. Animal models have shown that oxidative stress may be pathogenic in pulmonary hypertension.
Tammy O. Wichman   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy